Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

Seoul National University

Status: Completed

Conditions: Breast Disease; General Anesthesia

Treatments: Drug: use of rocuronium when the LMA is inserted

Study type: Interventional

Funder types: Other

Identifiers

NCT01035021

LMA_M_relax

Details and patient eligibility

About

The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).

Enrollment: 160 patients

Sex: Female

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-70 year
• american society of anesthesiologist status 1-2
• elective general anesthesia

Exclusion criteria

• known or predicted difficult airway
• recent sore throat
• mouth opening less than 2.5 cm
• at risk of aspiration

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

160 participants in 2 patient groups

group N

Active Comparator group

Description:

Anesthesia is induced with propofol and remifentanil and LMA is inserted by the standard technique according to eht manufacturer's instruction. Rocuronium is administered for the operation.

Treatment:

Drug: use of rocuronium when the LMA is inserted

group R

Active Comparator group

Description:

Anesthesia is induced with a propofol and remifentanil and rocuronium 0.06 mg/kg is injected. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction.

Treatment:

Drug: use of rocuronium when the LMA is inserted